Having trouble reading this email? View the web version here \| Forward this email to a colleague

MET ONE 3400 from HACH LANGE

Take a look at how air particle counting is carried out in a clean room. What do you see? Typically for compliance reasons most air particle counting results are printed out on thermal paper and then scanned in for digital archiving. Analysis is frequently achieved by hand typing the results into a spreadsheet or the laboratory database.

The new MET ONE 3400 Simply Paperless from HACH LANGE changes this by making the 21 CFR part 11 compliant data available as a pdf file directly from the instrument:

Immediate Time Saving: Save at least 2 hours a day by stopping the manual tearing, scanning and copying of portable air particle counting data
Less Contamination: Traditional printouts fade with time and produce particles
Eliminate Data Transcription Errors: An Excel compatible export removes the possibility of errors
Keep your existing SOP: The pdf format is identical to the standard printed results so your existing SOP and QA procedures should require little or no change
Patent Pending Secure Data Transfer: The MET ONE 3400 offers embedded secure data transfer

Leading edge technology from HACH LANGE enables you to simplify your routine air particle counting and save valuable time. The MET ONE 3400 Simply Paperless is the ideal instrument for Clean Room Classification, ISO 14644 Clean Room Verification and monitoring Aseptic Pharmaceutical Production. Visit www.particle.com for full details and to request a quotation.

For more infomation, click here >>

Featured whitepaper

Whitepaper: New Support for ISO 14644-1
Author: HACH LANGE
Changes in ISO 14644-1 to improve confidence in quality for critical life-science applications. Tony Harrison, UK Subject Matter Expert to ISO TC209 Working Group.

Whitepapers also available for download:

Increase the Physiological Relevance of HIV Models with RoboSep™
Author: STEMCELL Technologies

A comparison of the attributes of the AccuGENX-ID microbial sequencing methods versus MicroSEQ v2.0
Author: Accugenix

Autoantibody biomarker panels for improved disease diagnosis
Author: Oxford Gene Technology

Utilizing Colony-Forming Cell Assays In Toxicity Testing
Author: STEMCELL Technologies

An Interview with Dr. John Rossi
Author: Integrated DNA Technologies

RNA-Seq Data Comparison with Gene Expression Microarrays
Author: illumina

The importance of being profiled: Improving drug candidate safety and efficacy using cross-target profiling
Author: Merck Millipore

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- B&W Tek, Inc.
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- CAMO Software AS
- Catalent Pharma Solutions
- CI Precision
- EMD Millipore
- Expo Technologies, LLC.
- GE Analytical Instruments
- HACH LANGE GMBH
- I Holland Limited
- Lonza
- Merck Millipore
- Patheon Inc
- Peter Huber Kältemaschinenbau
- Porvair Sciences Ltd
- Randox Pharma Services
- Rapid Micro Biosystems
- Realia

Sandoz to acquire Fougera Pharmaceuticals

Novartis’s generic drugs division Sandoz has agreed to buy Fougera Pharmaceuticals for $1.53bn in cash in a deal that creates the world’s biggest generics company focused on dermatology medicines...

Read the full story >>

More pharmaceutical & life science news

		Results of clinical phase III study of once-monthly aripiprazole IM depot formulation for the treatment of schizophrenia presented at APA Results from a clinical phase III clinical trial...

		Pfizer announces new long-term relapse prevention data for PRISTIQ® (desvenlafaxine) 50 mg/day Pfizer announced new data presented at the 165th Annual Meeting of the APA...

		Roche provides update on Phase III study of dalcetrapib Roche announced that following the results of the second interim analysis of the dalcetrapib dal-OUTCOMES Phase III trial...

		Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly Results of the largest Phase III study...

		Pfizer stops Phase 3 trial Of Lyrica (pregabalin) capsules CV in neuropathic pain associated with HIV neuropathy Pfizer has stopped a Phase 3 clinical trial of Lyrica in patients with neuropathic pain...

		James Shannon named GlaxoSmithKline Chief Medical Officer James Shannon has been named GSK’s Chief Medical Officer, effective 1 May...

		Pfizer reports top-line results from Phase 3 trial of Lyrica (pregabalin) capsules CV in patients with inadequately treated painful diabetic peripheral neuropathy Pfizer announced that a Phase 3 randomized withdrawal design study for Lyrica in patients...

		Alan Schafer to head Population Genetics Population Genetics Technologies Ltd., has appointed Alan Schafer, PhD to the post of Chief Executive Officer...

		Genzyme announces regulatory approvals of expanded Waterford, Ireland manufacturing plant FDA and the EMA approve 2nd operation for filling and finishing product...

		Roche reports positive study of RoACTEMRA given by subcutaneous injection Roche announced that the SUMMACTA study met its primary endpoint...

		Abbott announces collaboration with Syngene to open first nutrition R&D center in India Abbott plans to establish its first nutrition R&D center with Syngene...

		GlaxoSmithKline plc appoints two Non-Executive Directors to its Board GlaxoSmithKline plc announces that Ms. Lynn Elsenhans and Ms. Jing Ulrich will join the Board...

analytica 2012 - Exclusive video interviews

		Waters interviewed at analytica 2012 Erik Junius, Director Informatics Europe at Waters speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

		Protea interviewed at analytica 2012 Alessandro Baldi, VP and General Manager at Protea speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

		AnalytikJena interviewed at analytica 2012 Andrea Glomb, General Manager International Sales, AnalytikJena speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

		B&W Tek interviewed at analytica 2012 Enrique Lozano Diz, Global Product Manager at B&W Tek, inc speaks to European Pharmaceutical Review at analytica 2012.

		Rigaku interviewed at analytica 2012 Elizabeth Yarbrough, Product Marketing Manager at Rigaku speaks to European Pharmaceutical Review at analytica 2012.

		Charles River Laboratories at analytica 2012 Yvonne Boss, European In-Vitro Specialist Sales Manager at Charles River Laboratories speaks to European Pharmaceutical Review at analytica 2012.

		BaySpec interviewed at analytica 2012 Eric Bergles, Vice President of Sales and Marketing at BaySpec is interviewed by European Pharmaceutical Review at analytica 2012.

Conferences, events & exhibitions:

Molecular Diagnostics Europe
10 - 11 May 2012 London, UK

Rational and Safe Prescribing – the way forward
11 May 2012 Dublin, Ireland

Advances in Raman spectroscopy in pharmaceutical analysis
17 May 2012, London, UK

60th ASMS Conference on Mass Spectrometry and Allied Topics
20 - 24 May 2012 Vancouver, Canada

Life Science User Group
16 May 2012, Cork, Ireland

Life Science User Group
17 May 2012, Livingston, Scotland

Life Science User Group
22 May 2012, Milano, Italy

Life Science User Group
24 May 2012, Lyon, France

Pharma Outsourcing & Procurement Summit 2012
21 - 22 May 2012 Berlin, Germany

International Conference on Genomics
24 - 26 May 2012, Copenhagen, Denmark

Biobanking
11 - 12 July 2012, London, UK


This email was sent to [email address suppressed] Click here if you no longer wish to receive the European Pharmaceutical Review email newsletter This email was sent by: European Pharmaceutical Review, Russell Publishing Ltd, Court Lodge, Hogtrough Hill, Brasted, Kent, TN16 1NU, United Kingdom